Biphasic release of immunoreactive endothelins following acute pulmonary thromboembolism in pigs

被引:7
作者
Tsang, J
Battistini, S
Dussault, P
Stewart, K
Qayumi, KA
机构
[1] Univ British Columbia, Pulm Res Lab, Dept Med, Vancouver, BC V6Z 1Y6, Canada
[2] Univ British Columbia, Dept Surg, Vancouver, BC V6Z 1Y6, Canada
[3] Univ Laval, St Foy, PQ G1K 7P4, Canada
关键词
pulmonary embolism; pulmonary hypertension; endothelins (ETs); vascular damage; thrombin; hypoxemia; ventilation perfusion mismatch;
D O I
10.1097/00005344-200036051-00066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this investigation was to study the role of endothelins (ETs) in the pathogenesis of acute pulmonary thromboembolism (PTE). Eighteen piglets (20 +/- 3 kg) were anesthetized and ventilated with 100% oxygen, five of them then served as controls. Acute thromboembolic injury in the lung was induced by injecting 15-25 ml of preformed clots into the left lower lobar pulmonary artery during thoracotomy. Pulmonary arterial pressure (Ppa) increased by at least 2.5-fold from baseline. During the subsequent 8 h, seven blood samples were collected from the left atrium and assayed for immunoreactive ETs. The results showed that following PTE: (1) Ppa remained elevated but cardiac output remained constant throughout the experiments; (2) plasma level of immunoreactive ETs increased in the embolized group compared to controls and the profile of immunoreactive ET release suggested a biphasic response. We conclude that the release of these vasocontractile and bronchoconstrictive mediators after PTE may contribute to ventilation perfusion mismatching and account for the pulmonary hypertension and deterioration of gas exchange that are often seen clinically.
引用
收藏
页码:S221 / S224
页数:4
相关论文
共 20 条
[1]   Thrombolytic therapy of pulmonary embolism - A comprehensive review of current evidence [J].
Arcasoy, SM ;
Kreit, JW .
CHEST, 1999, 115 (06) :1695-1707
[2]   Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines [J].
Battistini, B ;
Forget, MA ;
Laight, D .
SHOCK, 1996, 5 (03) :167-183
[3]  
BATTISTINI B, 1998, PULM PHARMACOL THER, P1179
[4]   Chronic thromboembolic pulmonary hypertension: The disease, the diagnosis, and the treatment [J].
Bergin, CJ .
SEMINARS IN ULTRASOUND CT AND MRI, 1997, 18 (05) :383-391
[5]  
DALONZO GE, 1984, CLIN CHEST MED, V5, P411
[6]   Coronary constriction and consequent cardiodepression in pulmonary embolism are mediated by pulmonary big endothelin and enhanced in early endothelial dysfunction [J].
Dschietzig, T ;
Laule, M ;
Alexiou, K ;
Schrör, K ;
Baumann, G ;
Stangl, K .
CRITICAL CARE MEDICINE, 1998, 26 (03) :510-517
[7]   EXPRESSION OF ENDOTHELIN-1 IN THE LUNGS OF PATIENTS WITH PULMONARY-HYPERTENSION [J].
GIAID, A ;
YANAGISAWA, M ;
LANGLEBEN, D ;
MICHEL, RP ;
LEVY, R ;
SHENNIB, H ;
KIMURA, S ;
MASAKI, T ;
DUGUID, WP ;
STEWART, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (24) :1732-1739
[8]  
GIAID A, 1993, LANCET, V341, P1550
[9]   Thrombin regulation of endothelin-1 gene in isolated human pulmonary endothelial cells [J].
Golden, CG ;
Nick, HS ;
Visner, GA .
CHEST, 1998, 114 (01) :63S-64S
[10]   Characterization of endothelin release from guinea-pig tracheal epithelium: Influence of proinflammatory mediators including major basic protein [J].
Hay, DWP ;
Van Scott, MR ;
Muccitelli, RM .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 1997, 10 (04) :189-198